Working… Menu

Evaluation of Efficacy and Accuracy of a Cordless Ultrasonic Dissection System (SCUD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01929928
Recruitment Status : Completed
First Posted : August 28, 2013
Last Update Posted : February 12, 2016
Medtronic - MITG
Information provided by (Responsible Party):
David Iannitti, Atrium Health

Brief Summary:
The purpose of this study is to test the efficacy of a new cordless ultrasonic dissection system.

Condition or disease
Surgical Procedures, Operative

Detailed Description:

The Sonicision device offers the ability to achieve hemostasis and vessel dissection with a cordless system. The ultrasonic device yields coagulation and transection of vessels by conversion of electrical energy into ultrasonic vibration through a piezoelectric or magnetic transducer, which is the causation of heat induction at the jaws of the instrument through friction. The Sonicision device is able to seal vessels up to 5 mm and transection division of 10 cm segments. The Sonicision device features the following:

  1. Cordless design to improve freedom and movement;
  2. Simplified set up that may possibly increase operating room efficiency;
  3. Dual-mode energy control to increase procedure focus;
  4. Improved mobility secondary to cordless system.

Currently all devices are connected to a generator by a cable, which can lead to the cable wrapping around the device, tangle with other instruments and become inadvertently contaminated. There are several advantages with regards to utilization of a cordless device to include: improved intra-operative storage, avoidance of bundling multiple cords from various instruments that may limit instrument mobility and portability which may lead to the ability to operate with advanced surgical equipment in third world settings, trauma and surgery centers.

The study group will consist of 150 patients, male and female adults, who present with the need for general surgery in which an ultrasonic dissection device and/or a vessel sealing device will be utilized. Patients will be identified prospectively via consultation with the general surgeon. Data will be collected addressing the following variables: versatility, dissection time, vessel diameter, reliability, efficiency, tissue response, steam production, blood loss, tissue response, thermal spread, desiccation and sealing time. A tentative total of ten individual tissue specimens will be obtained by the surgeon during surgery and after the utilization of the Sonicision Cordless Ultrasonic Dissection System. The patient's histologic sample will be followed after surgery in order to determine efficacy of the vessel seal. Subsequently, the patient's information will be deidentified and the patient assigned a study number to which all further analysis will be tied. Patient participation will include time of surgery through discharge from the hospital. Study data will be collected and managed utilizing an electronic database.

Layout table for study information
Study Type : Observational
Actual Enrollment : 110 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sonicision Cordless Ultrasonic Dissection System in General Surgery: A Prospective Post-market Observational Study to Evaluate the Efficacy and Accuracy of a Cordless Ultrasonic Dissection System
Study Start Date : January 2013
Actual Primary Completion Date : February 2015
Actual Study Completion Date : May 2015

Surgical Patients

Primary Outcome Measures :
  1. Placement of Sonicision Cordless Ultrasonic Dissection Device [ Time Frame: 1 year ]
    Evaluation of device placement will be measured based on vessel sealing variables: number of applications, vessel site, type of tissue to be sealed, number of seals to achieve hemostasis, number of activations, number of successful seals, number of failed seals, tissue sticking, tissue color, thermal spread and desiccation.

  2. Efficacy of Sonicision Cordless Ultrasonic Dissection Device [ Time Frame: 1 year ]
    Efficacy of device will be measured based on intra-operative and post-operative complication variables: estimated blood loss, blood transfusion, complications intra-operative and post-operative.

Secondary Outcome Measures :
  1. Device Complications [ Time Frame: 1 year ]
    Functional evaluation of device based on the variables: device malfunction, number of battery and generator changes during a procedure.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from the division of Hepatobiliary Surgery at Carolinas Medical Center in Charlotte, NC.

Inclusion Criteria:

General surgery in which an ultrasonic dissection device will be utilized Adult male and females age 18 and older

Exclusion Criteria:

Surgery involving bone Surgery involving contraceptive tubal occlusion Indication for emergency surgery Suspected inability or the inability to comply with trial procedures Employee at the investigational center, sponsor or sponsor's representative, relative or spouse of the investigator Emergency Surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01929928

Layout table for location information
United States, North Carolina
Carolinas Medical Center
Charlotte, North Carolina, United States, 28204
Sponsors and Collaborators
Atrium Health
Medtronic - MITG
Layout table for investigator information
Principal Investigator: David A Iannitti, MD Atrium Health
Layout table for additonal information
Responsible Party: David Iannitti, PI, Atrium Health Identifier: NCT01929928    
Other Study ID Numbers: 12-12-03B
First Posted: August 28, 2013    Key Record Dates
Last Update Posted: February 12, 2016
Last Verified: February 2016